Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Registry following people with heart and brain conditions in China

Collects data on people with heart and brain disease together.

Plain-language title generated from the registry record
Registry title: Registry of Multicenter Brain-Heart Comorbidity in China

Key facts

Where
Beijing, Fuzhou, Harbin, Kunming, Shanghai, Shanxi, Shenzhen, Xiamen, and Zhengzhou, ChinaSee the 14 sites

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The registry is looking for adults who have been newly diagnosed with a heart or brain blood-vessel disease, such as heart attack, atrial fibrillation, heart failure or stroke.

Age
Over 18 years old (minimum age 18 Years).
Sex
All sexes can join.
Disease stage
A newly diagnosed heart or blood-vessel disease, found by ICD-10-CM codes: I21, I22, I24 (ischaemic heart disease), I46 (cardiac arrest), I48 (atrial fibrillation/flutter), I50 (heart failure), I71 (aortic disease), I60 (subarachnoid haemorrhage), I61 (intracerebral haemorrhage), I63 (cerebral infarction), I65, I66 (narrowed or blocked brain arteries), I67.1 (cerebral aneurysm), I67.5 (moyamoya disease), Q28.2 (brain vessel arteriovenous malformation).

Main reasons for not taking part

  • People who refuse to take part in the registry cannot join.

Read by machine on 9 November 2026.

Where in China

  • Beijing Anzhen Hospital, Capital Medical UniversityBeijing, ChinaNot yet recruiting
  • Beijing Chaoyang Hospital, Capital Medical UniversityBeijing, ChinaNot yet recruiting
  • Beijing Tiantan Hospital,Capital Medical UniversityBeijing, ChinaTaking people
  • Chinese People's Liberation Army (PLA) General HospitalBeijing, ChinaNot yet recruiting
  • Peking University First HospitalBeijing, ChinaNot yet recruiting
  • Xuanwu Hospital, Capital Medical UniversityBeijing, ChinaNot yet recruiting
  • The First Affiliated Hospital of Fujian Medical UniversityFuzhou, ChinaNot yet recruiting
  • The First Affiliated Hospital of Harbin Medical UniversityHarbin, ChinaNot yet recruiting
  • The Second Affiliated Hospital of Kunming Medical UniversityKunming, ChinaNot yet recruiting
  • Huashan Hospital of Fudan UniversityShanghai, ChinaNot yet recruiting
  • Shanxi Provincial People's HospitalShanxi, ChinaNot yet recruiting
  • Shenzhen Qianhai Shekou Free Trade Zone hospitalShenzhen, ChinaNot yet recruiting
  • The First Affiliated hospital of Xiamen UniversityXiamen, ChinaNot yet recruiting
  • The First Affiliated Hospital of Zhengzhou UniversityZhengzhou, ChinaNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Beijing Tiantan Hospital
Trial code
NCT05961748
Record updated
21 September 2023
Original description
This study is a multi-center, prospective, registry study. This research was supported by the National Key Research and Development Program. To establish a domestic multi-center, large-scale "brain-heart comorbidity" dynamic database platform including clinical, sample database, image and other multi-dimensional information requirements, through the construction of a multi-center intelligent scientific research integration platform based on artificial intelligence.Read full original descriptionShow less

Registry of Multicenter Brain-Heart Comorbidity in China

This study is a multi-center, prospective, registry study. This research was supported by the National Key Research and Development Program. To establish a domestic multi-center, large-scale "brain-heart comorbidity" dynamic database platform including clinical, sample database, image and other multi-dimensional information requirements, through the construction of a multi-center intelligent scientific research integration platform based on artificial intelligence.

Any of newly diagnosed cardiovascular related diseases were identified via ICD-10-CM codes: I21, I22, I24 (Ischaemic heart diseases) [i.e., ACS], I46 (cardiac arrest), I48 (Atrial fibrillation/flutter), I50 (Heart failure), I71 (Aortic disease), I60 (subarachnoid hemorrhage), I61 (intracerebral hemorrhage), I63 (Cerebral infarction), I65 (Occlusion and stenosis of precerebral arteries), I66 (Occlusion and stenosis of cerebral arteries), I67.1 (cerebral aneurysm), I67.5 (moyamoya diseases), Q28.2 (Arteriovenous malformation of cerebral vessels).

The data is stored on the brain-heart comorbidity warehouse via a physical server at the institution's data centre or a virtual hosted appliance. The brain-heart comorbidity platform comprises of a series of these appliances connected into a multicenter network. This network can broadcast queries to each appliance. Results are subsequently collected and aggregated. Once the data is sent to the network, it is mapped to a standard and controlled set of clinical terminologies and undergoes a data quality assessment including 'data cleaning' that rejects records which do not meet the brain-heart comorbidity quality standards. The brain-heart comorbidity warehouse performs internal and extensive data quality assessment with every refresh based on conformance, completeness, and plausibility (http://10.100.101.65:30080/login).

Inclusion: age > 18 years old; Any of newly diagnosed cardiovascular-related diseases were identified via ICD-10-CM codes: I21, I22, I24 (Ischaemic heart diseases) [i.e., ACS], I46 (cardiac arrest), I48 (Atrial fibrillation/flutter), I50 (Heart failure), I71 (Aortic disease), I60 (subarachnoid hemorrhage), I61 (intracerebral hemorrhage), I63 (Cerebral infarction), I65 (Occlusion and stenosis of precerebral arteries), I66 (Occlusion and stenosis of cerebral arteries), I67.1 (cerebral aneurysm), I67.5 (moyamoya diseases), Q28.2 (Arteriovenous malformation of cerebral vessels).

Exclusion: ·refuse to participate in the registry.

ClinicalTrials.gov NCT05961748